Logo

Editor's Pick

Despite Record Speed, Nanopore Sequencing Faces Challenges for Use in Routine Diagnostics
Premium

Stanford researchers said the cost of their approach is in line with Illumina sequencing but did not share data on error rate and other benchmarks at this time.

SomaLogic's Illumina Codevelopment Deal Suggests Future of Label-Based Proteomics Lies in NGS
Premium

The assay development deal was "necessary to remain competitive" for SomaLogic, according to MD Anderson proteomics researcher Philip Lorenzi.

Sema4 to Embrace Co-CEO Model After $623M Acquisition of GeneDx
Premium

The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics.

Twist Bioscience Sees Demand for New Enzymatic DNA Synthesis Method; Stays Mum on Timeline, Details
Premium

The South San Francisco-based company claims the new technique is plug-and-play, low cost, scarless, and scalable but said it needs more engineering.

Protein-Based Liquid Biopsy Panel Assesses Tumor Microenvironment, Shows Prognostic Potential
Premium

A panel of 13 circulating proteins related to the tumor microenvironment may provide prognostic clues to prostate cancer progression.

Jan 7, 2022

Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom
Premium

Jan 7, 2022

Genomics, MDx M&A Activity Exploded in 2021 Driven by COVID-19 Testing Tailwinds

Jan 7, 2022

International Team Debuts New Platform for DIY Genetic Analysis and Interpretation
Premium

Jan 5, 2022

Facing Criticism, EHR Vendors Say They're Making Progress in Supporting Genomics
Premium

Dec 16, 2021

Seven Bridges Genomics to Foster Partnerships Between Health Systems, Pharmas With New Subsidiary
Premium

Dec 16, 2021

Diagnostic Developers Pursue SARS-CoV-2 Omicron Assays for Surveillance, Potential Clinical Use
Premium

Dec 16, 2021

Singular Genomics Launches G4 Sequencing Platform
Premium

Dec 16, 2021

CDC Grants Could Indicate Shift Toward More Federal Funds for Public Health Lab Construction
Premium

Dec 10, 2021

Long Cell-Free DNA Molecules Could Provide New Target for Noninvasive Prenatal Testing
Premium

Dec 10, 2021

Linus Biotechnology Looks to Human 'Exposome' as Biomarker for Autism Spectrum Disorders Test
Premium

Dec 9, 2021

RxPONDER Update Yields No Clear Guidance on Chemo Decisions for Younger Breast Cancer Patients
Premium

Dec 6, 2021

Helix Study Finds Tie Between HLA Allele, Side Effects of SARS-CoV-2 Vaccines
Premium

Nov 19, 2021

Most Genetic Counselors Encounter Discrepant Variant Classifications, Must Work Out Interpretations
Premium

Nov 15, 2021

MiDiagnostics Developing qPCR Platform for SARS-CoV-2 Breath Testing
Premium

Nov 12, 2021

Meridian Bioscience Looks Beyond COVID-19 for Growth in FY22
Premium

Nov 12, 2021

Childhood Brain Tumors in Crosshairs of New CHOP-led Sequencing Biobank Effort
Premium

Nov 11, 2021

Sysmex Inostics Sees Ultra-Sensitive Leukemia Liquid Biopsy as Potential CDx
Premium

Nov 10, 2021

Fulgent Genetics Details Diversification, Expansion Strategies
Premium

Nov 9, 2021

Invitae Unveils Plans to Expand Cancer Testing Portfolio
Premium

Nov 9, 2021

Harvard, Oxford-Developed Algorithm Uses Evolutionary Data to Predict Disease Variants
Premium

Breaking News
The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.